共 94 条
[1]
Nussenblatt RB(1997)Uveitis in Behcet's disease Int Rev Immunol 14 67-79
[2]
Yates PA(2006)Behcet's disease Int Ophthalmol Clin 46 209-233
[3]
Michelson JB(2005)Current concepts in the etiology and treatment of Behcet's disease Surv Ophthalmol 50 297-350
[4]
Evereklioglu C(2010)Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet’s disease Graefes Arch Clin Exp Ophthalmol 248 709-714
[5]
Kaburaki T(1997)Ocular immunopathology of Behçet’s disease Surv Ophthalmol 42 157-162
[6]
Araki F(1989)Fundus changes associated with Behcet's disease Graefes Arch Clin Exp Ophthalmol 227 340-344
[7]
Takamoto M(2006)Behcet's disease: general concepts and recent advances Curr Opin Ophthalmol 17 551-556
[8]
Okinaga K(2004)Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis J Rheumatol 31 1362-1368
[9]
Yoshida A(2005)Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease Arthritis Rheum 52 2478-2484
[10]
Numaga J(2010)Comparison of infliximab versus ciclosporine during the initial 6-month treatment period in Behcet’s disease Br J Ophthalmol 94 284-288